PABPN1 and oculopharyngeal muscular dystrophy: Most OPMD-afflicted patients have a wild type PABPN1 allele and a mutant (disease-causing) PABPN1 allele, so targeting the 3′-UTR of the mRNA of PABPN1 (with microRNAs or ribozymes) will suppress both alleles.